Matches in Wikidata for { <http://www.wikidata.org/entity/Q93214330> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q93214330 description "artículu científicu espublizáu en payares de 2018" @default.
- Q93214330 description "im November 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q93214330 description "scientific article published on 19 November 2018" @default.
- Q93214330 description "wetenschappelijk artikel" @default.
- Q93214330 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q93214330 name "Evaluation of D1/D5 Partial Agonist PF-06412562 in Parkinson's Disease following Oral Administration" @default.
- Q93214330 name "Evaluation of D1/D5 Partial Agonist PF-06412562 in Parkinson's Disease following Oral Administration" @default.
- Q93214330 type Item @default.
- Q93214330 label "Evaluation of D1/D5 Partial Agonist PF-06412562 in Parkinson's Disease following Oral Administration" @default.
- Q93214330 label "Evaluation of D1/D5 Partial Agonist PF-06412562 in Parkinson's Disease following Oral Administration" @default.
- Q93214330 prefLabel "Evaluation of D1/D5 Partial Agonist PF-06412562 in Parkinson's Disease following Oral Administration" @default.
- Q93214330 prefLabel "Evaluation of D1/D5 Partial Agonist PF-06412562 in Parkinson's Disease following Oral Administration" @default.
- Q93214330 P1433 Q93214330-DA367A03-7E3A-4993-8C40-36224A418B37 @default.
- Q93214330 P1476 Q93214330-4FC57975-4E44-483A-93E5-BD0C67756252 @default.
- Q93214330 P2093 Q93214330-226CEE02-4CDD-412C-99DC-0CC96B79F193 @default.
- Q93214330 P2093 Q93214330-2D9E2CDC-6A78-46D6-84DD-E0A9937D26F8 @default.
- Q93214330 P2093 Q93214330-D64C5F3F-467E-4C41-8C26-1D5B5DB0BF4D @default.
- Q93214330 P2093 Q93214330-D9491CA0-09F4-45B7-8E0E-1A10C435CF3A @default.
- Q93214330 P2093 Q93214330-F8260BE9-E64B-438A-BB0A-2964D89DCF6B @default.
- Q93214330 P304 Q93214330-A264C208-E4CD-4B7C-BCB5-92CEB66039FA @default.
- Q93214330 P31 Q93214330-9DFCBBBF-1F1F-4787-9751-F0E2143276AE @default.
- Q93214330 P356 Q93214330-AD597347-9B32-47A8-BFB3-724923353F9C @default.
- Q93214330 P433 Q93214330-D3435244-90F4-4D7C-9BBF-35788F836DBC @default.
- Q93214330 P478 Q93214330-989FA20C-6CD0-4E40-9A82-3765813161C0 @default.
- Q93214330 P577 Q93214330-27568622-B2F3-4C51-B015-3A93BC684352 @default.
- Q93214330 P698 Q93214330-7EBDDFA9-E9CE-4D56-9B6F-F6F54DB418F7 @default.
- Q93214330 P921 Q93214330-8174F066-E573-4D85-ABAB-E80BA248046D @default.
- Q93214330 P356 000492498 @default.
- Q93214330 P698 30453303 @default.
- Q93214330 P1433 Q15764918 @default.
- Q93214330 P1476 "Evaluation of D1/D5 Partial Agonist PF-06412562 in Parkinson's Disease following Oral Administration" @default.
- Q93214330 P2093 "David L Gray" @default.
- Q93214330 P2093 "Kathleen Thayer" @default.
- Q93214330 P2093 "Spyros Papapetropoulos" @default.
- Q93214330 P2093 "Sridhar Duvvuri" @default.
- Q93214330 P2093 "Wenlei Liu" @default.
- Q93214330 P304 "262-269" @default.
- Q93214330 P31 Q13442814 @default.
- Q93214330 P356 "10.1159/000492498" @default.
- Q93214330 P433 "5-6" @default.
- Q93214330 P478 "18" @default.
- Q93214330 P577 "2018-11-19T00:00:00Z" @default.
- Q93214330 P698 "30453303" @default.
- Q93214330 P921 Q11085 @default.